|
|||||||||||||||
|
|||||||||||||||
 |
|||||||||||||||
Sexually
Transmitted Diseases > LGV Project
Lymphogranuloma Venereum (LGV) Project Some files on this page require Adobe Acrobat or Adobe Reader.
 Lymphogranuloma venereum (LGV) is a systemic, sexually transmitted disease (STD) caused by a type of Chlamydia trachomatis (serovars L1, L2, or L3) that rarely occurs in the United States and other industrialized countries. However, the Netherlands (MMWR Oct. 29, 2004) and other European countries have reported increases in LGV proctitis among men who have sex with men (MSM). The MMWR article describes The Netherlands’ LGV finding including clinical signs and symptoms along with CDC’s 2002 STD Treatment Guidelines for LGV. Using LGV testing technology not commercially available (LGV genotyping), CDC has assisted state and local health departments in identifying patients with LGV in cities across the United States. The majority of patients with LGV proctitis in the U.S. have been HIV-infected MSM....more
|
|||||||||||||||
Content provided by the Division of STD Prevention |
|||||||||||||||
|
|||||||||||||||
|
